Pharmacokinetic Profile of Epinephrine Nasal Spray Versus Intramuscular Epinephrine Autoinjector in Healthy Adults

An epinephrine nasal spray (ENS) is under development for treatment of anaphylaxis. This analysis compared the pharmacokinetic (PK) profile of 13.2 mg ENS with that of the standard of care 0.3 mg intramuscular (IM) epinephrine autoinjector.
Source: Journal of Allergy and Clinical Immunology - Category: Allergy & Immunology Authors: Source Type: research